Marquette Medical Systems, Inc. Announces Antitrust Clearances for Merger

Business Wire, Nov 17, 1998

MILWAUKEE--(BUSINESS WIRE)--Nov. 17, 1998--Marquette Medical Systems, Inc. announced that all necessary antitrust clearances from U.S. and foreign regulatory authorities have now been obtained in connection with the proposed merger of Marquette with a subsidiary of General Electric Company. If the Marquette shareholders approve the merger at a special meeting to be held on Friday, November 20 and all other conditions to the merger are satisfied, it is expected that the transaction will close promptly following the special meeting. If the transaction closes on Friday, each share of Marquette common stock would be converted into 0.508 of a share of GE common stock, plus cash for any fractional share of GE common stock at the rate of $88.5625 per share.

Marquette Medical Systems, Inc. (NASDAQ: MARQ) is a leading manufacturer of medical electronics equipment and systems for diagnostic cardiology, patient monitoring and integration of clinical information, with headquarters in Milwaukee, Wisconsin. Additional information is available at the company's website, www.mei.com.